The largest database of trusted experimental protocols

Lc msd 1100 series

Manufactured by Agilent Technologies

The LC-MSD 1100 series is a liquid chromatography-mass spectrometry (LC-MS) system manufactured by Agilent Technologies. It is designed to perform qualitative and quantitative analysis of chemical compounds. The system combines a liquid chromatography module with a mass spectrometer, enabling the separation, identification, and quantification of complex mixtures.

Automatically generated - may contain errors

3 protocols using lc msd 1100 series

1

Endocannabinoid Profiling in Serum

Check if the same lab product or an alternative is used in the 5 most similar protocols
Serum concentrations of the endocannabinoids AEA were extracted from serum using Bond Elut C18 solid phase extraction columns (Varian Inc, Lake Forest, CA), as previously described (Hill et al., 2008 (link)). These extractions for AEA were done concurrent to those previously reported for 2-AG, on the same samples. The lipid was quantified in the lipid extracts by liquid chromatography-electrospray ionization-mass spectrometry (LC-ESI-MS; Agilent LC-MSD 1100 series) and quantified by isotope dilution as described previously (Patel et al., 2005 (link)). Congeners of AEA, the structural analogs oleoylethanolamide (OEA) and palmitoylethanolamide (PEA) were simultaneously assayed.
+ Open protocol
+ Expand
2

Quantifying Endocannabinoids in Tissue

Check if the same lab product or an alternative is used in the 5 most similar protocols
Concentrations of the endocannabinoids N-arachidonylethanolamine (AEA) and 2-arachidonylglycerol (2-AG) were extracted from tissue using a protocol adapted from Patel et al. 2003 (link). Briefly, tissue samples were homogenized in 2mL of acetonitrile with 84 pmol [2H8]AEA and 186pmol [2H8]2-AG using glass rods. Samples were sonicated for 60 min and frozen overnight at −20°C to precipitate proteins. The supernatant was obtained following centrifugation at 1500 × g for 2 min at 4°C, was dried under N2 and the lipids were resuspended in methanol. The two endocannabinoids were isolated and quantified by liquid chromatography-electrospray ionization-mass spectrometry (LC-ESI-MS; Agilent LC-MSD 1100 series) and quantified by isotope dilution as described previously (Patel et al. 2003 (link)).
+ Open protocol
+ Expand
3

Quantification of Endocannabinoids and Hormones in Neuroimaging Study

Check if the same lab product or an alternative is used in the 5 most similar protocols
Upon arrival at the imaging center, an MRI safe catheter was placed in participant’s left arm and samples were collected through antecubital venipuncture. Blood plasma samples were collected at baseline (before dinner) and at four time points following the dinner. Blood serum samples for ECS analysis were only collected at 7:30 pm while subjects were inside the MRI scanner, 90 min after the initiation of dinner (in between the 2nd and 3rd fMRI run). Prior to drawing each sample, 1.5–2 mL of blood were drawn off to remove potentially diluted blood from the dead space of the catheter. Samples were put on ice, centrifuged, aspirated, divided into aliquots, and stored at −80°C until assay.
Serum levels of 2-arachidonoylglycerol (2-AG) and 2-oleoylglycerol (2-OG) were extracted using the Bond Elut C18 solid-phase extraction columns (1 ml; Varian Inc, Lake Forest, CA). Serum samples were processed and the two compounds were quantified using chemical ionization liquid chromatography/mass spectrometry (LC-ESI-MS; Agilent LC-MSD 1100 series, Ramsey, MN), as previously described (Patel et al., 2005 (link)).
We used enzyme-linked immunosorbent assay (ELISA) kits for total plasma ghrelin (human ghrelin, Millipore), plasma leptin (human leptin, Millipore), and cobas e411 analyzer (Roche) for plasma insulin, and serum cortisol.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!